Cutera (NSDQ:CUTR) this week fired president & CEO James Reinstein after the aesthetic device maker missed expectations for its 2018 top line, naming COO Jason Richey as interim chief executive. Brisbane, Calif.-based Cutera said Jan. 7 that it expects to post sales of $161 million to $163 million for last year, short of the consensus Wall Street […]
Cutera slashes guidance on FDA warning, shares fall
Shares in Cutera have fallen more than 20% today after the company cut its sales guidance for the third quarter and full year. The Brisbane, Calif.-based company said that it now expects to post sales of approximately $40 million in the third quarter. Cutera said that in light of the adjustment, it lowered its full […]
NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018
NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]
Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017
Vascular Dynamics said early this month it tapped former NuVasive Inc. (NSDQ:NUVA) exec and Ellipse Technologies CEO Ed Roschak as its new president and chief executive. Prior to joining Mountain View, Calif.-based Vascular Dynamics, Roschak served as prez and CEO of Ellipse Technologies, which he saw through a $410 million acquisition by NuVasive. He then took up […]
Lumicell taps ex-Accuray COO Londy as CEO | Personnel Moves July 18, 2017
Lumicell said last week it tapped former Accuray (NSDQ:ARAY) chief operating officer Kelly Londy as its new chief exec, with founder W. Lee moving to take the role of prez & chief scientific officer. Prior to holding the COO position at Accuray, Londy has held leadership positions at GE Healthcare (NYSE:GE) and Royal Philips (NYSE:PHG), Lumicell said. “We are […]
Getinge ousts CEO Myers after 18 months, shares slide | Personnel Moves August 22, 2016
Getinge ousts CEO Myers after 18 months, shares slide After less than 18 months in the corner office, Getinge (PINK:GETI B) has removed CEO Alex Myers from his position, sending shares down as much as 6% in trading. The shift was due to “different views” on the direction of the company, and changes are going into […]
ViewRay registers for initial public offering worth up to $69 million | Medtech Wall Street news for the week of February 23, 2015
Cutera expands stock buyback to $40M
Covidien promotes Hanson to group president role | Personnel Moves
What medtech companies is BlackRock buying into?
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
MassDevice Network
@MassDevice
LinkedIn
YouTube